Summer 2020 Life Science Investor Relations

It’s summertime! You and your life science company made it through the initial shock of the COVID-19 pandemic, made adjustments and are now moving ahead under your “new normal.” You’ve done digital one-on-ones with investors, updated the Street on any disruptions to your clinical trial progress and tightened up your cash burn. Your stock may have recovered to post COVID-19 levels, and you are highly encouraged by the recent string of successful life science IPOs and follow-ons.

While summertime is typically a slower time on the IR Calendar, as with all things in 2020 – this “COVID Summer” is likely to look a bit different. Three thoughts from our team as we head into the Q2 earnings season in July and August:

  1. Pay attention to commentary from Q2 bellwether reports in our sector.

    Johnson & Johnson kicked off the Q2 earnings season today with mixed data, and investors will be taking stock of underlying healthcare demand and other key fundamentals for our sector over the next two weeks. Stay informed, and be prepared for potential inbound questions on any commentary that may directly or indirectly relate to the drivers in your company performance and outlook.

  2. When reporting your Q2, be candid about where you have visibility and where you do not.

    Out of necessity, many companies gave cautionary language around milestones and timelines, or pulled guidance altogether as COVID-19 hit. As you update your outlook for the rest of the year, it is very important as part of Q2 reporting, do be transparent and keep investors current as to where you have improved visibility and where uncertainty or challenges remain.

  3. Digital 1x1s open the calendar for summer outreach, but use investor time wisely.

    The current environment has increased the reception for “off-calendar” 1×1’s, and many companies want to take advantage of the more flexible format to engage with investors this summer. The deal calendar has been exceptionally busy in our sector however, and investors will prioritize accordingly. If you have important or timely updates, reach out. Otherwise we recommend waiting until you do have timely updates, or when availability opens up, likely heading into the fall.

Stay safe, and good luck! As always, please reach out to the MacDougall team if you would like to talk investor relations. Send me a note at smichelmore@macbiocom.com.

Creative Services

Digital Media
& Content

More than a Tweet
Building your brand and voice is a key function of digital media, but, with the right goals in mind, digital media can be much more. Meet your audiences where they are by building digital campaigns and content that help to connect and engage your stakeholders.
  • Social media strategy & content
  • Narrative building
  • Blog creation and execution
  • Metrics, monitoring and reporting
  • Social listening
  • Executive digital profile strategy and management
  • Influencer monitoring and engagement
  • Digital advertising
  • Content creation, design and marketing
  • Video creation and podcasting

Investor
Relations

Credibility is your most important asset
Investor relations is about building trust, transparency and liquidity. The MacDougall IR team has helped many clients bridge from private to public and showcase our public clients to new investors and analysts.
  • Audience targeting
  • Shareholder communication
  • IPO preparations and communications
  • Conference calls & webcasts
  • Conference outreach and support
  • Presentations
  • Special events
  • R&D days
  • Perception audits

Digital
& Creative

A picture is worth a thousand words
Visual first impressions are so important in this era of precipitous information. Our digital and creative services team are true life science artists devoted to visual storytelling and capturing eyeballs.
  • Branding & identity​
  • Visual storytelling​
  • Logo design​
  • Website design & development​
  • Scientific illustration & MOA graphics​
  • Infographics / data visualization​
  • Animation & video production​
  • Presentation design​
  • Scientific posters​
  • HTML emails & newsletters
  • Advertisements

Thought
Leadership

Be known for making a difference
Thought leadership campaigns open many channels to promote both a personal brand as well as your organization. Let’s pick a subject and run with it together.
  • Executive profile building​
  • Strategic counsel
  • Presentation coaching​
  • Speech writing​
  • Media training​
  • Social media​

Scientific & Medical Communications

Show and tell

From preclinical to platform to Phase 3 results, strategic medical and scientific communications is the cornerstone to building visibility and credibility with your target audiences.

  • Medical and scientific meeting support
  • Patient recruitment for clinical trials
  • Disease awareness campaigns
  • Patient advocacy outreach
  • Data communications
  • KOL identification and development
  • Custom scientific symposia/events​

Public
Relations

We love telling stories
Public relations is about building your network and getting other people talking about you. We want to help you build buzz and credibility at the same time.
  • Company debuts​
  • Media campaigns ​
  • Social media strategy & content​
  • Press releases writing, editing & pitching​
  • Ongoing trend story development & pitching​
  • Conference tracking & management​
  • Disease awareness campaigns
  • Clinical trial recruitment campaigns
  • Media monitoring & analytics
  • Events​

Business
Advisory

Think before you talk
We have seen it all. Helping our clients navigate the macro and micro ups and downs of the life science and healthcare industry is our passion.
  • Corporate branding, positioning and message development
  • Product and technology branding
  • Public policy advisory
  • Crisis communications
  • Strategic communications plans
  • Capital markets advisory
  • Scientific and medical publication and presentation strategies
  • Board presentations
  • Competitive intelligence
  • M&A advisory & rebranding
  • Corporate rebranding